Athenex and Xiangxue Life create joint venture Axis; Xiangxue grants TCR rights

15:40 EDT 6 Jul 2018 | Elsevier Business Intelligence

Athenex Inc. and Xiangxue Life Science (XLS; a division of Guangzhou Xiangxue Pharmaceutical Co. Ltd.) created a 55/45 joint ...

More From BioPortfolio on "Athenex and Xiangxue Life create joint venture Axis; Xiangxue grants TCR rights"